Description du projet
Une solution sûre pour les patients infectés
Les épidémies de maladies infectieuses sont responsables de milliers de décès dans le monde. Les habitudes de déplacement de notre société moderne augmentent les risques pour la santé, l’économie et la sécurité liés à ces épidémies. Les unités d’isolement spécialisées (UIS) ont été développées par EpiGuard, composé d’un groupe de médecins qui ont œuvré pour contenir l’infection Ebola. Ils ont proposé la solution EpiShuttle après trois ans de recherche; une UIS réutilisable, au toit rigide (polycarbonate), pour une personne. Au titre de l’initiative EpiShuttle 2.0 EpiGuard entend combiner la technologie moderne de désinfection au gaz et EpiShuttle afin de rendre leur technologie rentable et applicable au marché mondial plus large d’une valeur de plusieurs milliards d’euros.
Objectif
The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.
Champ scientifique
Mots‑clés
Programme(s)
Régime de financement
SME-2 - SME instrument phase 2Coordinateur
1634 Gamle Fredrikstad
Norvège
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.